Suppr超能文献

潜在的抗肿瘤药物。35. 4'-(9-吖啶基氨基)甲磺酰基间茴香胺类似物的抗肿瘤(L1210)效力与DNA结合之间的定量关系。

Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues.

作者信息

Baguley B C, Denny W A, Atwell G J, Cain B F

出版信息

J Med Chem. 1981 May;24(5):520-5. doi: 10.1021/jm00137a009.

Abstract

Factors influencing dose potency of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) analogues in L1210 assays have been investigated by multiple regression analysis. The dependent variable was D40, the dose to provide 40% life extension in L1210 tests. Independent variables examined were chromatographic Rm values, as a measure of agent lipophilic-hydrophilic balance; Rm2; log K, where K is the agent-DNA association constant for poly[d(A-T)]; log T1/2, the half-life for congener thiolytic cleavage; and agent pKa values. A regression equation containing terms in Rm2 and log K was derived with the latter term accepting the greater proportion of the biological variance. DNA binding, of acridine substituted m-AMSA variants, is the most important factor influencing dose potency. Modeling of log K for 3-substituted derivatives provided an equation in substituent R constants and molar refractivities (MR).

摘要

通过多元回归分析研究了影响4'-(9-吖啶基氨基)甲磺基间茴香胺(m-AMSA)类似物在L1210试验中剂量效力的因素。因变量是D40,即在L1210试验中使寿命延长40%的剂量。所研究的自变量包括色谱Rm值,作为药剂亲脂性-亲水性平衡的量度;Rm2;log K,其中K是聚[d(A-T)]的药剂-DNA结合常数;log T1/2,同系物硫解裂解的半衰期;以及药剂的pKa值。推导出了一个包含Rm2和log K项的回归方程,后一项解释了更大比例的生物学变异。吖啶取代的m-AMSA变体的DNA结合是影响剂量效力的最重要因素。对3-取代衍生物log K的建模得到了一个关于取代基R常数和摩尔折射度(MR)的方程。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验